Fischer Medical Ventures Intrinsic Value
Fischer Medical Ventures intrinsic value. Fischer Medical Ventures (FISCHER) median intrinsic value is ₹47.52 from 3 valuation models (range ₹10–₹58), vs current price ₹32.80 — +44.9% upside (Trading Below Calculated Value), margin of safety 31.0%. For current market price and key ratios, visit Fischer Medical Ventures share price today.
FISCHER Valuation Methods Summary — DCF, Graham Number & P/E
Fischer Medical Ventures intrinsic value across 3 models vs current price ₹32.80 — upside/downside and value range per method. Compare with FISCHER fair price to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹58.33 | ₹52.50 - ₹64.16 | +77.8% | Book Value/Share: ₹58.33, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹47.52 | ₹42.77 - ₹52.27 | +44.9% | Revenue/Share: ₹59.39, P/S: 0.8x |
| Dividend Yield Method | dividend | ₹9.84 | ₹8.86 - ₹10.82 | -70.0% | DPS: ₹0.05, Target Yield: 3.5% |
FISCHER Intrinsic Value vs Market Price — All Valuation Models
Fischer Medical Ventures fair value range ₹10–₹58 vs current market price ₹32.80 across 3 valuation models. Read Fischer Medical Ventures dividend policy for the complete payout history and dividend yield track record.
FISCHER Intrinsic Value Analysis — Undervalued or Overvalued?
Fischer Medical Ventures median intrinsic value ₹47.52, current price ₹32.80 — Trading Below Calculated Value by 44.9%, margin of safety 31.0%.
What is the intrinsic value of FISCHER?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Fischer Medical Ventures (FISCHER) is ₹47.52 (median value). With the current market price of ₹32.80, this represents a +44.9% variance from our estimated fair value.
The valuation range spans from ₹9.84 to ₹58.33, indicating ₹9.84 - ₹58.33.
Is FISCHER undervalued or overvalued?
Based on our multi-method analysis, Fischer Medical Ventures (FISCHER) appears to be trading below calculated value by approximately 44.9%.
FISCHER Financial Health — Key Ratios vs Industry Benchmarks
Fischer Medical Ventures financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 14.93 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -12.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.58x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
FISCHER Cash Flow Quality — Operating & Free Cash Flow
Fischer Medical Ventures operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-101 Cr | ₹-104 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹-86 Cr | ₹-149 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-7 Cr | ₹-22 Cr | Negative Cash Flow | 3/10 |